As I See It

All about herbal medicines


Here’s good news for those who like to take herbal medicines, instead of the regular medicines, for their ailments, thinking it is cheaper. Herbals are now a P4-billion industry. Why not? It consists of putting a few leaves in a teabag, or grinding the leaves into powder and putting it in a capsule, or add a binder and make tablets and then putting the result in a beautiful package and selling them.  These are not medicines with curative values, mind you, but classified as “food supplements,” which is why they escape the scrutiny of the Food and Drug Administration (FDA).

“No therapeutic claims.” The law mandates that each package of herbals contain this warning, meaning that the product does not claim to cure any disease. But how many Filipinos know what “No therapeutic claims” means? And on the contrary, herbal manufacturers do make those claims in their advertisements and commercials, with celebrities endorsing (for a fee, of course) some of the products. The herbal companies actually spend more for their advertisements and commercials than for the herbal medicine itself.

And the herbals are packaged like regular medicine—in pill, tablet, capsule or syrup form. And they are sold in drugstores at almost the same prices as regular medicines.

The diseases that the herbals claim to cure range from the very common to the most deadly. They range from the common cold to cancer, heart disease, high blood pressure, stroke, diabetes, arthritis, liver and intestinal diseases. They even claim to improve eyesight. Name the disease, they have an antidote for it.

Almost every day, a new herbal hits the market. The companies probably spend more time concocting names for their new products than doing research to find out the efficacy of their products.

Of course, there are plants that do have medicinal properties. In fact, many of the regular medicines are extracted from plants. And every year, new species with medicinal properties are being discovered.

But extracting the medicinal ingredient from plants and making it into regular medicine are different from packaging the leaves and selling them as medicine. And aside from its medicinal ingredients, a plant might contain other ingredients that are harmful.

For example, the mahogany seed became a fad sometime ago as an anti-hypertensive. So thousands of Filipinos were chewing mahogany seeds instead of taking regular medicines against high-blood pressure, although there are so many of the latter in the market that they are now very inexpensive. It turned out that mahogany seeds are also toxic and some of those taking them died. A friend-journalist of mine, of all people, was one of those who died from chewing mahogany seeds.

A sister-in-law of mine was having chemotherapy for cancer when a friend of hers suggested that she take herbals as they had been good for her. So she stopped her chemotherapy and switched to herbals.  Both she and her friend died soon after.

The Department of Health, particularly the FDA, has been negligent in its duties in not guiding and advising the public about herbals. The FDA claims that herbals are not within its jurisdiction since they are not medicines but food supplements. The advertising industry has also been remiss in its duties by not warning the herbal companies about their false advertising. Not one of the herbals being marketed has undergone the rigorous research and testing that regular medicines undergo. One of the hundreds of handsomely paid legislators we have should file a bill in Congress putting the herbals within the ambit of the FDA.

This is where we come in with the good news about herbals. RiteMed, a division of the Filipino multinational United Laboratories, Inc., has decided to join the lucrative herbal medicine industry. But with a difference: You can be sure that each and every herbal being sold by RiteMed has been tested and proven to alleviate, if not cure, the symptoms of some illnesses. Each of them has been approved by the Department of Science and Technology.

Unlike the other herbal companies, it took a while for RiteMed to go into herbals because of challenges along the way.  Producing herbal medicine from out of the identified indigenous plants requires not just the identification of the needed active ingredient and their eventual harvest. It goes beyond that. There are several hurdles that have to be satisfied before one can formulate the herbal tablet or syrup that would deliver the needed medicinal punch.

Aside from monitoring the quality of the soil on which the indigenous plants (earlier identified to have the capability to battle a disease) can grow the same type of plant extract needed for the herbal tablet or syrup, clinical trials are needed. For example, ampalaya leaves from plants grown in Makiling do not necessarily have exactly the same properties as those from Cavite or Ilocos because the soils in which they grow are different.

This is precisely what RiteMed has done: It has partnered with DOST and UP Manila National Integrated Research Program on Medicinal Plants (Nirpromp), both of which have the necessary clinical trials that enabled the company to enter the herbal market, confident that it remains true to its quality image.

RiteMed consulted Nirpromp scientists before it embarked on coming up with lagundi tablets and syrup that alleviate certain ailments. It also surveyed the various sources of lagundi to make sure that they get only the best plant materials. If not propertly handled from harvest to processing, plant materials are prone to bacterial and fungal contamination. Hence. strict quality control protocols have been established.

Follow Us

Follow us on Facebook Follow on Twitter Follow on Twitter

More from this Column:

Recent Stories:

Complete stories on our Digital Edition newsstand for tablets, netbooks and mobile phones; 14-issue free trial. About to step out? Get breaking alerts on your mobile.phone. Text ON INQ BREAKING to 4467, for Globe, Smart and Sun subscribers in the Philippines.

Short URL: http://opinion.inquirer.net/?p=18521

Tags: Ailments , diseases , FDA , health , Herbal Medicines

  • manariwa

    The death of ancient culture and wisdom (e.g., Aetas, Chinese, Hindus, Mayans, et al.), particularly in medicine began when the commercial greed of pharmaceutical companies led them to work with the state and the legal system to outlaw or to practically outmode the use of cheap, accessible herbal nutrition and cure. Scientific research is good; but thousands of years of constant and effective use of many of these herbal cures have been readily put aside by those who find synthetic drugs cheaper to produce and more profitable to promote to the masses of gullible people. 

    The Cultural Revolution in China under Mao tried to outlaw ancient Chinese medicine for allegedly being a superstitious practice; but it was restored later under Deng Xiaoping when scientific findings proved it otherwise. And so now, because manufacturers cannot stop people from using herbal medicine, they ride on its efficacy. But, as long as we have cheap and available herbal medicine, we won’t complain. Just don’t make us believe your premises.

    Btw, this article seems like a rehashed ad/column. I remember  commenting before that what we have is the BFAD (Bureau of Food and Drugs) not FDA (the US counterpart).

  • RayP1766

    So Neal, apparently we should trust these new herbals because you and the manufacturer say so?  Certainly, there would be a potential for a conflict of interest if we relied solely on the manufacturer’s claims. Therefore your particular qualifications on this matter are …….?  Please, don’t be shy!

    FDA doesn’t endorse them because as you said in your article, the FDA claims that herbals are not within its jurisdiction.  So who are we left with?  DOST and Nirpromp.  Both reputable organisations indeed. 

    So I think it’s incumbent on you, having used your opinion column (some would say completely irresponsibly) to endorse a particular brand of herbals, to ensure that in the next week you secure and publish statements from DOST and Nirpromp in your column stating the therapeutic values of the RiteMed products in relation to particular diseases, afflictions or other ailments.

    Otherwise, you should cease and desist from publicly endorsing something you have no technical expertise to do – it is not only incredibly unethical; it’s also stupid and potentially very dangerous.

  • Ricci Santiago

    Ritemed – product of UNILAB. INQ likes this kind of news-info-advertisement-garbage. i wasted my time reading it and at the bottom is an advert. 

  • pinsky

    To me i believe on the potency of herbal medicines if you yourself concocted it based on the practice of ancient times. However these herbal medicines concocted for commercial sale is too risky to rely on. It could pose as a threat to one’s health instead of cure. It could be a venin that slowly ends one’s life.
         Commercialize herbal medicine must be doubted why? 1. In its label there’s a strict warning that it has no therapeutic claim meaning no curative effect. 2. The integrity of the manufacturing company is in limbo meaning a fly by night company in the making. 3. Assurance that the herbals used as food supplement is the actual herbal leaf or bark use for concoction of the medicine and etc.
         It’s advisable yet incumbent upon the government to take cognizance of this matter for life is the is at stake.

  • Mottainai

    I’d like to have my 4 minutes back.

  • joeldcndcn


  • mangpepe

    ayaw marinig ng mga drug manufacturer iyan

Copyright © 2014, .
To subscribe to the Philippine Daily Inquirer newspaper in the Philippines, call +63 2 896-6000 for Metro Manila and Metro Cebu or email your subscription request here.
Factual errors? Contact the Philippine Daily Inquirer's day desk. Believe this article violates journalistic ethics? Contact the Inquirer's Reader's Advocate. Or write The Readers' Advocate:
c/o Philippine Daily Inquirer Chino Roces Avenue corner Yague and Mascardo Streets, Makati City, Metro Manila, Philippines Or fax nos. +63 2 8974793 to 94


  • Tagle: Christ’s resurrection a message of hope to faithful
  • Aquino vows to intensify anti-corruption drive further
  • Unease in Vatican over cardinal’s luxury flat—report
  • Nepal calls off search for missing guides on Everest—official
  • Pope’s Easter Message ‘Urbi et Orbi’
  • Sports

  • Rain or Shine grabs No.4, sends Ginebra to 8th
  • Red-hot Alaska rips injury-depleted San Mig Coffee
  • Pacquiao courtesy call to Aquino set for Monday
  • Nick Calathes suspension a reminder of supplement risk
  • Teague scores 28 as Hawks soar past Pacers in Game 1
  • Lifestyle

  • Angono petroglyphs in danger of disappearing
  • Britain’s baby Prince George visits Australian zoo
  • Noli Yamsuan, Cardinal Sin’s ‘official’ photographer: ‘I could smell the aftershave lotion of the Pope’
  • Simplifying and lightening life
  • Where to go for Easter night-out
  • Entertainment

  • Show-biz celebrities’ other choices of summer getaway
  • Why ‘Noah’ can’t dock his ark at Philippine theaters
  • Acclaimed artist goes wild while on holiday
  • Believing in this mermaid
  • Missing Xian
  • Business

  • Top-selling insurance agent opens her dream café
  • Connecting and transacting with one another
  • Building wealth for health
  • Why Mandaue Foam buys, rather than rents, space
  • A workplace of new possibilities
  • Technology

  • Nasa’s moon-orbiting robot crashes down
  • Netizens pay respects to Gabriel Garcia Marquez
  • Nokia recalls 30,000 chargers for Lumia 2520 tablet
  • Facebook rolls out ‘nearby friends’ feature
  • Netizens seethe over Aquino’s ‘sacrifice’ message
  • Opinion

  • Epiphany
  • Unpaid creditor vs distressed debtor
  • Moving on
  • From culinary desert to paradise
  • Response to China: ‘Usjaphil’
  • Global Nation

  • Tim Tebow’s charity hospital in Davao seen to open in 7 months
  • OFW died of Mers-CoV in Saudi Arabia, says family
  • Aquino, Obama to tackle US pivot to Asia during state visit
  • Asia seeks Obama’s assurance in territorial spats
  • Cesar Chavez movie sparks memories of Fil-Am labor leaders
  • Marketplace